GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (OTCPK:CALZF) » Definitions » Days Payable

Polynovo (Polynovo) Days Payable : 603.23 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Polynovo Days Payable?

Polynovo's average Accounts Payable for the six months ended in Dec. 2023 was $4.43 Mil. Polynovo's Cost of Goods Sold for the six months ended in Dec. 2023 was $1.34 Mil. Hence, Polynovo's Days Payable for the six months ended in Dec. 2023 was 603.23.

The historical rank and industry rank for Polynovo's Days Payable or its related term are showing as below:

CALZF' s Days Payable Range Over the Past 10 Years
Min: 113.53   Med: 212.44   Max: 503.16
Current: 503.16

During the past 13 years, Polynovo's highest Days Payable was 503.16. The lowest was 113.53. And the median was 212.44.

CALZF's Days Payable is ranked better than
92.11% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 72.685 vs CALZF: 503.16

Polynovo's Days Payable increased from Dec. 2022 (490.38) to Dec. 2023 (603.23). It may suggest that Polynovo delayed paying its suppliers.


Polynovo Days Payable Historical Data

The historical data trend for Polynovo's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Days Payable Chart

Polynovo Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 116.04 235.26 383.57 318.34 193.42

Polynovo Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 677.25 441.37 490.38 307.06 603.23

Competitive Comparison of Polynovo's Days Payable

For the Medical Devices subindustry, Polynovo's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polynovo's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's Days Payable distribution charts can be found below:

* The bar in red indicates where Polynovo's Days Payable falls into.



Polynovo Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Polynovo's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

Days Payable (A: Jun. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2022 ) + Accounts Payable (A: Jun. 2023 )) / count ) / Cost of Goods Sold (A: Jun. 2023 )*Days in Period
=( (1.315 + 1.838) / 2 ) / 2.975*365
=1.5765 / 2.975*365
=193.42

Polynovo's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (1.838 + 7.027) / 2 ) / 1.341*365 / 2
=4.4325 / 1.341*365 / 2
=603.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polynovo Days Payable Related Terms

Thank you for viewing the detailed overview of Polynovo's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Polynovo (Polynovo) Business Description

Traded in Other Exchanges
Address
320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo (Polynovo) Headlines

From GuruFocus

Half Year 2021 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2022 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Extraordinary Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Investor Update Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Full Year 2021 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2022 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024